143 related articles for article (PubMed ID: 31629724)
21. Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.
Iberri DJ; Hoppe RT; Advani RH
Curr Treat Options Oncol; 2015 Sep; 16(9):45. PubMed ID: 26187795
[TBL] [Abstract][Full Text] [Related]
22. Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation.
Feugier P; Labouyrie E; Djeridane M; Jenabian A; Dubruille V; Berthou C; Ghandour C; Desablens B; Chaït Y; Casassus P; Delwail V; Ifrah N; Le Mevel A; Lamy T; Brière J; Colonna P; Andrieu JM
Blood; 2004 Nov; 104(9):2675-81. PubMed ID: 15231567
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
24. Radiation Dose Reduction in Early-Stage Hodgkin Lymphoma.
Shah BA; Oh C; Wu SP; Karp JM; Grossbard M; Gerber NK
Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):820-829. PubMed ID: 32800712
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
Moding EJ; Advani R; Rosenberg SA; Hoppe RT
Radiother Oncol; 2018 Dec; 129(3):507-512. PubMed ID: 30539763
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
[TBL] [Abstract][Full Text] [Related]
27. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
28. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
[TBL] [Abstract][Full Text] [Related]
29. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
[TBL] [Abstract][Full Text] [Related]
30. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.
Olszewski AJ; Shrestha R; Castillo JJ
J Clin Oncol; 2015 Feb; 33(6):625-33. PubMed ID: 25584010
[TBL] [Abstract][Full Text] [Related]
31. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy in early stage classical Hodgkin lymphoma: past, present and future.
Zhang W
Chin Clin Oncol; 2015 Mar; 4(1):6. PubMed ID: 25841713
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
Nogová L; Reineke T; Brillant C; Sieniawski M; Rüdiger T; Josting A; Bredenfeld H; Skripnitchenko R; Müller RP; Müller-Hermelink HK; Diehl V; Engert A;
J Clin Oncol; 2008 Jan; 26(3):434-9. PubMed ID: 18086799
[TBL] [Abstract][Full Text] [Related]
34. Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern era.
Zapatero A; López MA; Cerezo L; De Vidales CM; MarIn A; Pérez-Torrubia A
Hematology; 2002 Feb; 7(1):43-50. PubMed ID: 12171776
[TBL] [Abstract][Full Text] [Related]
35. Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India.
Parambil BC; Narula G; Prasad M; Shah S; Shet T; Shridhar E; Khanna N; Laskar S; Gujral S; Sankaran H; Banavali S
Pediatr Blood Cancer; 2020 Feb; 67(2):e28058. PubMed ID: 31724304
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases.
Yoshifuji K; Umezawa Y; Ichikawa A; Watanabe K; Miura O; Yamamoto M
In Vivo; 2019; 33(5):1599-1604. PubMed ID: 31471410
[TBL] [Abstract][Full Text] [Related]
37. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
[TBL] [Abstract][Full Text] [Related]
38. Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients.
Ezzat AA; Ibrahim EM; El Weshi AN; Khafaga YM; AlJurf M; Martin JM; Ajarim DS; Bazarbashi SN; Stuart RK; Zucca E
Head Neck; 2001 Jul; 23(7):547-58. PubMed ID: 11400243
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia.
Hapgood G; Zheng Y; Sehn LH; Villa D; Klasa R; Gerrie AS; Shenkier T; Scott DW; Gascoyne RD; Slack GW; Parsons C; Morris J; Pickles T; Connors JM; Savage KJ
J Clin Oncol; 2016 Jul; 34(21):2493-500. PubMed ID: 27269949
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study.
Goh Z; Latimer M; Lewis KL; Cheah CY; Ciaccio PD; Cushion T; Hawkes EA; Harrop S; Ku M; Campbell A; Hamad N; Wood EM; Chung E; Chen PY; Cochrane T
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):370-378. PubMed ID: 36804727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]